From March 11, 2011 to March 13, 2011, Chairman Jinan Song, COO Dr. Hui Chang and other business executive presented at the Natural Products Expo West in Anaheim, California. This year's event witnessed the largest number of exhibits in its 31-year history at the Anaheim Convention Center, hosting 3533 exhibits and more than 58,000 industry members. Company representatives met with a wide array of industry participants including consumers, chain store owners, distributors, wholesalers, and R&D professionals. The Company's booth received very positive reception and immediate interest in business partnership from a few European and American health food companies. The record number of exhibits this year is indicative of the positive overall trend in the global health food industry and bodes well for our highly competitive probiotics products.

On March 8, 2011, senior officials from the Shanghai Food and Drug Administration (SHFDA) visited our manufacturing and R&D facility in Qingpu. Visitors included the Deputy Party Secretary and Deputy Director of the SHFDA and three other officials. The delegation was briefed on the Company’s bulk product qualities, safety measures and quality assurance during the production process. Senior officials gave high regards to the sophistication of the laboratory equipments used in the R&D center, such as U.S.-made Thermo freezer for preserving strains under negative 80 Celsius degrees, Denmark-made APV homogenizer for yogurt application testing, and U.S.-made NBS automatic fermenter for fermentation testing. The delegation also complimented on our professional R&D team consisting of 40 Master and above degree holders and international project management experience. The group toured the production site, raw material and finished products warehouse and spoke positively of the Company’s GMP quality assurance system and HCAAP raw material safety system.

On January 21, 2011, senior managers of Royal DSM N.V. paid a follow-up visit to our manufacturing facility in Qingpu. Visitors included the Director of Strategy and Marketing of DSM Food Specialties and the Sales Manager of DSM (China) for additives of dairy products and enzymes. Chairman & CEO Mr. Jinan Song and COO Dr. Chang hosted the delegation.

On January 8, 2011, Byron Roth, Chairman & CEO of Roth Capital, visited the corporate headquarters in the Zhabei District, and the R&D center and the manufacturing facility in Qingpu. Chairman & CEO Mr. Song Jinan and other executive officers met with Mr. Roth and discussed recent corporate developments.

On December 9, 2010, the senior management of Royal DSM N.V. (China) visited the R&D center and the manufacturing facility located in Qingpu. The delegation was accompanied by COO Dr. Chang and VP of production Mr. Li. Both parties conducted in-depth discussions regarding strategic development, growth models, and market expansion. DSM’s visiting officials gave high regards toward the integrated management system, solid R&D team and sophisticated production equipment, and they expressed interest in advancing their business cooperation.

Headquartered in Heerlen, the Netherlands, DSM N.V. is a global leader in life science and material development. The activities of DSM are grouped into: nutrition, pharma, performance materials, polymer intermediates and base chemicals and materials.

On September 30, 2010, the President of Danisco (China) visited the R&D center and the manufacturing facility in Qingpu. The delegation was accompanied by Chairman & CEO Mr. Song Jinan. Both parties shared views on a variety of topics such as probiotics applications, research and development, and sales and marketing. Danisco’s visiting officials praised the technological capacity and rapid growth of China-Biotics.

Danisco is a leading global enterprise in the development and manufacturing of enzymes, specialty food ingredients and bio-based solutions. In January 2011, Danisco was acquired by DuPont at $5.8 billion.